Aldeyra Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.2M | $24.9M | $14.6M |
| FY2017 | $1.2M | $39.6M | $20.0M |
| FY2018 | — | $86.6M | $47.4M |
| FY2019 | $14.5M | $48.1M | $44.4M |
| FY2020 | $11.4M | $59.5M | $77.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.2M | $24.9M | $14.6M |
| FY2017 | $1.2M | $39.6M | $20.0M |
| FY2018 | — | $86.6M | $47.4M |
| FY2019 | $14.5M | $48.1M | $44.4M |
| FY2020 | $11.4M | $59.5M | $77.9M |